Ulta Beauty ULTA
Consumer Cyclical · Specialty Retail · Synthos Deep Dive · 2026-07-03
The Overview
Ulta Beauty runs the big beauty stores in strip malls all over America — makeup, skincare, fragrance, hair care, plus in-store salons. It is the biggest player of its kind in the US, it makes very good money on the capital it uses, and it carries almost no debt it can't easily cover.
Right now the stock is cheap relative to its own history and to the market: you're paying about 16 dollars for every 1 dollar of next year's expected profit, and the shares have fallen about a third from their high because investors worry beauty spending is cooling and rivals like Sephora and Amazon are taking share. Our verdict is Buy — Tactical: a good company at a fair-to-cheap price, worth owning in a smaller, value-style position rather than as a big long-term anchor.
Here's what our three scores mean in everyday terms:
- Downside Risk 4/10 (below average — relatively safe). It's already cheap and financially healthy, which cushions the fall, but it's a store-based retailer tied to how much people spend, so it can still swing with the economy.
- Growth Quality 6/10 (solid, not spectacular). The business earns terrific returns and has a real loyalty-club advantage, but sales are only growing a few percent a year, and a chunk of the per-share profit growth comes from the company buying back its own stock, not from selling more.
- Exponential Potential 3/10 (low). This is a mature US retailer. It should grind higher, but don't expect it to double quickly — there's no big new market opening up underneath it.
The one big worry: if American shoppers keep pulling back on beauty and competitors keep chipping away, Ulta's sales-per-store and profit margins shrink, and the cheap-looking stock turns out to be cheap for a reason.
Putting a number on it: our fair-value estimate is $540 against a current price of $517.50 — real upside if our numbers are right.
Our summary metrics
Cheap (16× fwd, 11.6× EV/EBITDA) with ~0.96× net-debt/EBITDA & 0.86 beta cushion the downside — but it is a consumer-cyclical retailer already down 35% on category & competitive worries.
Elite 45% ROE / 24% ROIC and a real loyalty moat, but only ~6% revenue growth and EPS growth is heavily buyback-assisted, not organic.
Mature US beauty retailer, growth decelerating to single digits; buybacks — not a widening TAM — do the lifting. No multibagger runway.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Mature US beauty retailer, growth decelerating to single digits; buybacks — not a widening TAM — do the lifting. No multibagger runway.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $671 (high $790 / low $550; 1 Strong Buy · 26 Buy · 19 Hold · 1 Sell) — context, not our anchor |
| Valuation | 17× trailing EPS · 16× FY26E · 14× FY27E · 11× FY30E · EV/S 1.7× · EV/EBITDA 11.6× |
| Technicals | Downtrend — $461, −35% off 52-wk high, below 50/200-DMA, RSI 44, −2.6% 12-mo (SPY +21%) |
| Conviction | Low — 1 net-bullish voice, +0.65 net, 1 reconciled claim (Invest Like the Best, 2022) |
| Position sizing | Tactical/value satellite, ~2–3%, scale in near lows |
What the experts actually said 2 traceable claims on ULTA · showing the highest-conviction voices
“On-site services—haircuts, yoga classes, pet washes, hot dogs—draw foot traffic that Amazon cannot replicate, reinforcing offline retail durability.”
“Ulta, one of the first companies Sean covered and pitched, is a portfolio holding up about 40%.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $517.50, 4% above the 50-day average ($497), 7% below the 200-day average ($556) — a mixed trend. 27% below the 52-week high of $707, 15% above the 52-week low of $451.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $517.50 is currently inside the band (band $499–$563).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 49.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 1.35, negative momentum.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = ULTA · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Ulta Beauty (NASDAQ: ULTA) is the largest specialty-beauty retailer in the United States, running more than 1,500 stores across all 50 states plus ulta.com and the Ulta Beauty app. Its differentiator is breadth — mass and prestige cosmetics, fragrance, skincare, hair care, and wellness under one roof — combined with in-store salon services (hair, skin, brow, makeup) and the Ulta Beauty Rewards loyalty program (a ~40M+ member base that anchors repeat traffic). It also holds a growing shop-in-shop partnership footprint and is expanding internationally via its Space NK subsidiary (UK/Ireland luxury beauty), a Mexico joint venture, and a Middle East franchise. Fiscal year ends late January; the company is led by CEO Kecia Steelman and is based in Bolingbrook, Illinois.
Revenue mix (from filings):
- By type: FMP's segmentation for ULTA is sparse and legacy — recent years show only line items like gift-card breakage (~$27M FY2025), with older years breaking out E-commerce and Salon Services (~$301M salon revenue in FY2018, the last clean disclosure). In practice the near-totality of the ~$12.4B top line is retail product sales (cosmetics, skincare, fragrance, hair), with salon services and other a small single-digit slice. (Treat the FMP product segmentation as incomplete; the income statement is the reliable source.)
- By geography: FMP returns no geographic segmentation — the business is overwhelmingly US, with a small and newly growing international contribution via Space NK (UK/Ireland), the Mexico JV, and the Middle East franchise. US concentration is a stability feature and a growth-ceiling constraint at once.
The strategic frame is simple: defend a mature, high-return US store base (loyalty + assortment + salon experience), lean on buybacks to compound per-share value, and add modest new growth legs (international, wellness, shop-in-shops).
2. The expert thesis — why the (thin) panel is bullish (traceable)
Honest coverage note: the Synthos KB has essentially no expert breadth on ULTA — total_claims = 1. This is a fundamentals- and quant-driven call, not a conviction-panel call. There is exactly one traceable voice:
- Invest Like the Best (
invest_like_the_best-_ExmzmmijW4:5bef41ae4a, bullish, conviction 65, skill 1.0, dated 2022-07-18): the argument is that on-site services and experiences — "haircuts, yoga classes, pet washes, hot dogs" (the podcast's generic offline-retail example, of which Ulta's salons are the beauty analogue) — "draw foot traffic that Amazon cannot replicate, reinforcing offline retail durability." Applied to Ulta, the durable claim is that the salon + try-in-store experience is a genuine moat against pure e-commerce — a real, if dated (2022), and modest, signal.
That is the entire net-bullish case in the KB (+0.65 net conviction). There is no cautionary voice on file and no high-skill cluster. We therefore do not lean on the panel — the verdict rests on valuation, returns on capital, and the growth trajectory below. Readers who want a heavily expert-corroborated name should note this is not one.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 4 · Below-average | Cheap (16× fwd, 11.6× EV/EBITDA, ~5.4% FCF yield) with ~0.96× net-debt/EBITDA and 0.86 beta cushion the fall — but it's a consumer-cyclical retailer already −35% on real category/competitive worries. |
| Growth Quality | 6 · Solid | Elite 45% ROE / 24% ROIC and a genuine loyalty moat, but only ~6% revenue growth, margins drifting down slightly, and EPS growth is buyback-assisted rather than organic. |
| Exponential Potential | 3 · Low | Mature US beauty retailer, growth decelerating to single digits; buybacks — not a widening TAM — do the lifting. No multibagger runway from a $19.8B cap. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Comps re-accelerate (loyalty + international + shop-in-shops), gross margin holds ~40%; FY26/27E EPS beats toward ~$33; buybacks keep shrinking the share count; multiple re-rates to ~20×. | ~$660 (+43%) |
| Base (our anchor) | Management guidance roughly holds — FY26E EPS ~$28.4–$28.8, growing toward ~$30 blended; a durable-but-slow high-return retailer earns a ~18× multiple. | ~$540 (+17%) |
| Bear | Beauty category cools further, Sephora/Amazon take share, comps stall and margin slips; EPS stalls near ~$27; the multiple de-rates to ~14× (where it already sits on trough sentiment). | ~$380 (−18%) |
Synthos fair value = the base case, ~$540 (+17%), with the full $380–$660 span as the honest range. Our base sits below the Street's $671 consensus — we are less willing than the sell side to pay up for a low-single-digit-comp retailer — while our bear ($380) is below the Street's $550 low because we take the category/competition risk seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). ULTA is a high-return but low-exponential name:
- Forward growth: revenue CAGR FY25→FY30E ~5.8% ($12.39B → $16.43B); EPS CAGR ~11.2% ($25.64 → $43.65) — but the gap between the two tells the story: the per-share line grows roughly 2× the revenue line largely because the share count keeps shrinking (44.8M diluted shares TTM, down from 56.6M in FY2020). That is high-quality capital return, not organic acceleration.
- Acceleration (the 2nd derivative) is negative: revenue growth decelerated from the post-COVID surge (+18% FY2021, +9.8% FY2025) to management's guided 6–7% for FY2026, with comps guided just 2.5–3.5%. The steep-growth phase is behind it.
- Room to run: the US beauty TAM is large but mature and already well-penetrated by Ulta; the genuine new legs (international via Space NK, wellness, shop-in-shops) are real but small relative to a ~$12.4B base. At a $19.8B cap the constraint is demand growth, not size — there is no obvious path to a multibagger.
- Reinvestment runway: capex is modest (~$435M/yr, ~3.5% of sales) and returns on it are high, but the dominant use of cash is buybacks (~$901M FY2025, $555M in Q1 FY2026 alone; $1.3B left on a $3.0B authorization). That compounds per-share value steadily — it does not create exponential top-line growth.
Exponential Potential: Low (3/10). Own ULTA for a cheap multiple on a high-return, cash-generative franchise that shrinks its share count — not for a fast multibagger. This honest framing is why it's a Tactical/value position, not a Core compounder or a Degen moonshot.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY2025 (ended Jan 2026) $12.39B, +9.7% (FY2024 $11.30B, +0.8% on FY2023 $11.21B). The FY2025 reacceleration was partly the Space NK acquisition and new stores; underlying comps are mid-single-digit.
- Quarterly trajectory: Q1 FY2026 (ended May 2026) revenue $3.16B, +11.1% YoY, comps +5.3% (3.7% ticket, 1.6% transactions) — a strong start, EPS $7.74 vs $6.70 (+15.5%). Note comps benefited from Space NK and easier compares; the guide implies deceleration through the year.
- Margins: gross 39.3% TTM (40.1% in Q1 FY2026, up on lower shrink and better merchandise margin), operating ~12.5% TTM, net 9.4% TTM. Operating margin has drifted down from the ~16% post-COVID peak toward the low-teens as SG&A deleverages on strategic investments — a margin-normalization headwind to watch.
- Returns on capital (the real strength): ROE 44.8%, ROIC 23.9%, ROCE 34.7% — elite for a retailer and the core of the quality case.
- Earnings: net income $1.15B FY2025 (EPS diluted $25.64); TTM net income per share ~$27.16. Buybacks are the swing factor in per-share growth.
- Cash flow: operating CF $1.50B, capex −$435M, FCF ~$1.07B FY2025 (~5.4% FCF yield). Cash-generative and self-funding.
- Balance sheet: total debt $2.18B is almost entirely capitalized operating leases ($1.81B) — normal for a store fleet; net-debt/EBITDA ~0.96×, easily serviceable (interest coverage is enormous). No solvency concern.
6. Valuation — priced in or room?
This is the crux of the call: ULTA is cheap on almost every lens. 17× trailing EPS, 16× FY26E, 14× FY27E, ~11× FY30E, EV/Sales 1.7×, EV/EBITDA 11.6×, ~5.4% FCF yield, and a P/B that FMP flags as a weak spot only because equity is small relative to a high-return model. For a franchise earning 45% ROE with no real leverage, a mid-teens forward multiple is undemanding — the market is pricing structural deceleration and competitive share loss, not a healthy grower.
The bull's case is that mid-single-digit comps + steady buybacks + a stable ~40% gross margin support ~$30+ EPS and a re-rating back toward the high-teens/20×. The bear's case is that the multiple is correctly low because comps stall and margins keep normalizing down. Our base ~$540 (18× on ~$30 blended EPS) splits the difference and lands below the Street's $671. Street targets (context): consensus $671, high $790, low $550, median $700, on a 1 Strong Buy / 26 Buy / 19 Hold / 1 Sell split — the sell side is more constructive than we are; we treat that as context, not our anchor. Not a momentum buy; a quality-retailer-on-sale buy.
7. Technicals (from the FMP tech block)
- Trend: down. $461 sits below the 50-DMA ($496) and 200-DMA ($561), and the 50 is below the 200 (death-cross posture). MACD −9.6 (negative).
- Location: −35% off the 52-week high ($707) and only +2.3% off the 52-week low ($451) — this is a name trading near its lows, which is precisely the value setup, but also confirms the market's worry.
- Momentum: RSI(14) 44 — neither oversold nor overbought; no capitulation signal yet.
- Relative strength (the tell): ULTA −2.6% 12-mo vs SPY +20.6% and QQQ +30.3%; −14% 3-mo vs SPY +14%. Persistent underperformance of both the market and the Nasdaq — this is an out-of-favor name, not a leader.
- Read: technicals do not confirm the fundamental value case yet — the trend is down and there's no reversal signal. For a value entry that argues for scaling in near the lows rather than chasing, and waiting for a base to form before adding size. No urgency; patience is rewarded here.
8. Moat & competitive position
Ulta's moat is scale + assortment breadth + loyalty + experience: it is the largest US specialty-beauty retailer, the only national chain carrying mass and prestige beauty side by side, with in-store salons and a ~40M+ member rewards program that drives repeat traffic and first-party data. The Invest Like the Best claim (§2) captures the durable piece — the salon/try-in-store experience is hard for pure e-commerce to replicate. Returns on capital (24% ROIC, 45% ROE) are the quantitative proof the moat is real.
But the moat is contested and not widening: Sephora (via its Kohl's shop-in-shop expansion and prestige strength), Amazon (mass beauty and convenience), direct-to-consumer brands, and mass retailers (Target, Walmart beauty) all pressure share, and the beauty category itself is cooling off its post-COVID boom. The 35% drawdown is the market pricing exactly this. So: a genuine, high-return moat, but one defending a mature base rather than opening new ground.
Peer set (FMP-provided, market cap): these are broad consumer-cyclical comps rather than pure beauty peers — Best Buy $16.4B, Casey's General Stores $29.5B, Dick's Sporting Goods $20.2B, Darden $23.4B, Genuine Parts $18.4B, PulteGroup $25.5B, Restaurant Brands $25.9B, Tractor Supply $16.7B, Williams-Sonoma $26.8B, Geely $24.0B. Against these specialty retailers ULTA's ~24% ROIC and 11.6× EV/EBITDA screen as high-return and reasonably valued; its truest competitors (Sephora/LVMH, e.l.f., Coty, Amazon beauty) are not in the FMP list.
9. Management, capital allocation & guidance
- Capital allocation: shareholder-friendly and disciplined — modest, high-return capex (~3.5% of sales) plus aggressive buybacks ($901M FY2025; $555M in Q1 FY2026; $1.3B remaining on a $3.0B authorization). No dividend. Share count fell from 56.6M (FY2020) to 44.8M (TTM) — the buyback is the primary per-share growth engine.
- Insider activity: the recent Form 4s are almost entirely routine annual director equity awards (2026-06-10, 404 shares each at $0 — grants, not purchases) plus one small director open-market sale (George Mrkonic, 383 shares at $475.84 on 2026-06-15). Nothing that reads as a signal — no cluster of alarming discretionary selling.
- Management's own guidance (half-weighted — they talk their own book): the SEC 8-K (Item 2.02) earnings release dated 2026-06-02 is a real Q1 FY2026 release and updates full-year FY2026 outlook:
- Net sales growth 6–7% (unchanged)
- Comparable sales growth 2.5–3.5% (unchanged)
- Operating income growth 6.5–9% (raised from 6–9%)
- Diluted EPS $28.36–$28.80 (raised from $28.05–$28.55)
- Capex $400–450M (unchanged)
CEO Kecia Steelman framed FY2026 as "off to a strong start driven by broad-based growth across all channels and major categories" while flagging "an uncertain macroeconomic landscape." Weighting this at half (it is management's self-interested framing), the guidance is credible and consistent with our base case — mid-single-digit comps and ~$28.5–$28.8 EPS, which our ~$540 base capitalizes at ~18×.
10. Catalysts & what to watch
- Next earnings: 2026-08-27 (Q2 FY2026; Street EPS $6.16, revenue ~$2.98B). The key lines: comparable sales (does the mid-single-digit comp hold as compares get harder?) and gross/operating margin (shrink, merchandise margin, SG&A deleverage).
- Comp trajectory vs guide: management guided comps to decelerate from Q1's +5.3% toward the 2.5–3.5% full-year range — watch whether the slowdown is orderly or worse.
- Margin normalization: operating margin drifting from ~16% peak toward low-teens; the FY2026 op-income growth guide (6.5–9%) is the bogey.
- Competitive share: Sephora/Kohl's shop-in-shop rollout and Amazon beauty momentum — the structural share question.
- Buyback pace: $1.3B remaining; continued aggressive repurchase near lows is accretive and supportive.
- International (Space NK / Mexico / Middle East): small today, but the only genuine new top-line leg.
Thesis tripwires (what would change the call): two consecutive quarters of negative or sub-2% comps; gross margin falling below ~38%; operating margin breaking below ~11%; or a buyback pause. Any of these would push this from Tactical-Buy toward Watch.
11. Key risks
- Consumer-cyclical / category cooling (structural): beauty is discretionary; a softening US consumer pressures ticket and traffic directly. The 35% drawdown is largely this.
- Competitive share loss: Sephora (Kohl's shop-in-shops), Amazon, DTC brands, and mass retailers all pressure Ulta's mass+prestige position — the moat is contested, not widening.
- Margin normalization: operating margin has been drifting down from post-COVID peaks as SG&A deleverages on strategic investment; further slippage undercuts the EPS story.
- Growth is buyback-dependent: if the share-repurchase pace slows (or the multiple compresses so buybacks buy fewer shares' worth of value), per-share growth decelerates faster than revenue.
- Thin expert corroboration: unlike our conviction-track names, only one dated (2022) KB claim supports this — the call leans on fundamentals and quant, so it carries less independent validation.
12. Verdict, position sizing & monitoring
Buy — Tactical. ULTA is a genuinely high-quality retailer — 45% ROE, 24% ROIC, ~$1.07B FCF, no real leverage, a real loyalty/experience moat — trading at ~16× forward earnings and ~11.6× EV/EBITDA after a 35% drawdown, with management raising full-year EPS guidance. That is a good business on sale, and the base case (~$540, +17%) plus a cheap valuation floor make the risk/reward favorable. But the growth is mid-single-digit and decelerating, EPS growth leans on buybacks, the category is cooling, competition is real, and the technicals are in a downtrend — so this is a value/tactical satellite, not a Core forever-compounder.
- Sizing: tactical/value, ~2–3% of the book — a re-rating and buyback-compounding play, not an anchor. The downtrend argues for scaling in near the lows rather than a single lump; patience is rewarded.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $461.33.
- Single biggest risk: beauty-category cooling plus Sephora/Amazon share-taking compressing comps and margin — the reason the cheap multiple could stay cheap.
Provenance & disclosures
- Traceability: 1 KB claim, breadth 1, top skill 1.0 (Invest Like the Best), last claim 2022-07-18 — reconciled to a real
claim_id(cited inline). Thin coverage is disclosed plainly; this is a fundamentals/quant call, not a conviction-panel call. Fabricated conviction is structurally impossible (claim-ID reconciliation). - Data as-of: fundamentals 2026-05-02 (Q1 FY2026) · estimates & prices 2026-07-03 · expert claim 2022-07-18. Forward figures are analyst consensus (FMP), labeled as estimates.
- Management caveat: the FY2026 outlook in §9 is management's own guidance from the 2026-06-02 SEC 8-K (Item 2.02), half-weighted by design.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").